Genomic Health News (NASDAQ:GHDX)

Latest Genomic Health News Headlines
DateTimeSource
Headline
06/02/20088:30AMPRNUSGenomic Health Announces Expansion of Oncotype DX(R) Breast Cancer Test to Include Quantitative Estrogen Receptor (ER) and Proge
Study Published in the Journal of Clinical Oncology Proves Accurate Measurement of ER and PR Status Using Quantitative Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) REDWOOD CITY, Calif., June 2 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that the Journal of Clinical Oncology... More...>>
05/31/20084:00PMPRNUSGenomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies
- Results from Gene Identification Studies Presented at ASCO Support Further Exploration of Possible Tests to Predict Response to Targeted Therapies for Colon and Breast Cancers - REDWOOD CITY, Calif., May 31 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX), provider of the Oncotype DX(R) breast cancer assay... More...>>
05/08/20088:30AMPRNUSGenomic Health to Present at Bank of America 2008 Healthcare Conference and 7th Annual JMP Securities Research Conference
REDWOOD CITY, Calif., May 8 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Bank of America 2008 Healthcare Conference in Las Vegas, NV on Wednesday, May 14, 2008 at 3:20 p.m. Pacific Time. In... More...>>
05/06/20084:02PMPRNUSGenomic Health Announces First Quarter 2008 Financial Results and Business Progress
- Product Revenue Increased 78 Percent Compared to First Quarter of 2007 - REDWOOD CITY, Calif., May 6 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today reported financial results and business progress for the quarter ended March 31, 2008. Total revenue increased to $23.4 million in the first quarter... More...>>
04/29/20088:30AMPRNUSGenomic Health to Announce First Quarter 2008 Financial Results and Host Conference Call on Tuesday, May 6, 2008
REDWOOD CITY, Calif., April 29 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 6, 2008 at 4:30 p.m. Eastern Time to discuss its first quarter 2008 financial results. The call and webcast will follow the release of the... More...>>
04/28/20088:30AMPRNUSGenomic Health to Present at Morgan Stanley Global Healthcare Unplugged Conference
REDWOOD CITY, Calif., April 28 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Unplugged Conference in Key Biscayne, FL on May 2, 2008 at 8:30 a.m. Eastern... More...>>
03/28/20088:30AMPRNUSGenomic Health to Participate in Leerink Swann Roundtable Conference
REDWOOD CITY, Calif., March 28 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that Steven Shak, M.D., Genomic Health's Chief Medical Officer, will participate in Leerink Swann's Roundtable Conference, Bugs and Drugs: The Future of Molecular Diagnostics, in New York, NY on April 3, 2008... More...>>
03/12/20088:30AMPRNUSGenomic Health to Present at Lehman Brothers Global Healthcare Conference
REDWOOD CITY, Calif., March 12 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami, FL on March 19, 2008 at 5:15 p.m. Eastern... More...>>
03/03/20088:30AMPRNUSWomen Health Care Executives Names Genomic Health President Kimberly Popovits as 'Woman of the Year'
Popovits to be Honored at Gala Dinner in San Francisco on June 12, 2008 SAN FRANCISCO and REDWOOD CITY, Calif., Mar. 3 /PRNewswire/ -- Women Health Care Executives of Northern California (WHCE) announced today that Kimberly Popovits, president and chief operating officer of Redwood City-based Genomic Health, Inc., has... More...>>
02/08/20088:30AMPRNUSGenomic Health to Present at BIO CEO & Investor Conference
REDWOOD CITY, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Operations Officer, will present at the BIO CEO & Investor Conference in New York, NY on Feb. 12, 2008 at 10:15 a.m. Eastern Time. To access the live and... More...>>
02/05/20084:02PMPRNUSGenomic Health Announces Fourth Quarter and Year-End 2007 Financial Results and Business Progress and 2008 Financial Guidance
- Full-Year Revenue Increased 120 Percent Compared to 2006 - REDWOOD CITY, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today reported financial results and business progress for the fourth quarter and year ended December 31, 2007. Total revenue increased to $19.3 million in the fourth... More...>>
01/30/20088:30AMPRNUSGenomic Health to Announce Fourth Quarter and Year End 2007 Financial Results and Host Conference Call on Tuesday, February 5, 2
REDWOOD CITY, Calif., Jan. 30 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that the company will host a conference call and webcast on Tuesday, February 5, 2008 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year end 2007 financial results. The call and webcast will follow... More...>>
01/28/20088:30AMPRNUSGenomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
- Studies Presented at ASCO GI: American Society of Clinical Oncology Gastrointestinal Cancers Symposium to be Used in Selecting Final Genes for Colon Cancer Test - REDWOOD CITY, Calif., Jan. 28 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced the results of studies that have identified genes... More...>>
01/07/20088:30AMPRNUSGenomic Health Announces Collaboration With Pfizer to Develop Prognostic Test for Non-Metastatic Renal Cell Carcinoma
REDWOOD CITY, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) announced today a collaboration with Pfizer on the development of a genomic test to estimate the risk of recurrence following surgery for patients with Stage I-III renal carcinoma, clear cell type, that has not spread to other... More...>>
01/03/20088:30AMPRNUSGenomic Health to Present at 2008 JPMorgan Healthcare Conference
REDWOOD CITY, Calif., Jan. 3 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the 26th Annual JPMorgan Healthcare Conference in San Francisco, CA on Wednesday, January 9 at 9 a.m. Pacific Time. To... More...>>
01/02/20088:30AMPRNUSGenomic Health Reports Recommendation of Oncotype DX(R) in National Comprehensive Cancer Network Guidelines
REDWOOD CITY, Calif., Jan. 2 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today reported that the company's Oncotype DX(R) breast cancer assay, used to predict the likelihood of disease recurrence and the likelihood of chemotherapy benefit for a large portion of early-stage breast cancer patients, has... More...>>
12/17/20078:30AMPRNUSMultiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
Presentations Provide New Insights into Treatment Impact, Node-Positive Breast Cancer, Measuring ER/PR Scores REDWOOD CITY, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced results from multiple studies reinforcing the clinical utility of the company's Oncotype DX(R), a multi-gene... More...>>
12/15/20075:15PMPRNUSGenomic Health Announces Oncotype DX(R) Provides Additional Prognostic Benefit in Patients Assessed With Adjuvant Online
- Comparison Study Confirms Oncotype DX Recurrence Score Result Has Strongest Association with Breast Cancer Recurrence - SAN ANTONIO, Dec. 15 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced positive results from a study showing that the Oncotype DX Recurrence Score(TM) provides additional... More...>>
12/07/20078:30AMPRNUSGenomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
REDWOOD CITY, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that results from eight studies of the company's Oncotype DX(R) breast cancer test are scheduled to be presented at the 30th Annual San Antonio Breast Cancer Symposium, taking place December 13-16, 2007. Oncotype... More...>>
11/21/20078:30AMPRNUSGenomic Health to Present at 19th Annual Piper Jaffray Health Care Conference
REDWOOD CITY, Calif., Nov. 21 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Piper Jaffray Health Care Conference in New York, NY on November 28, 2007 at 1:00 p.m. Eastern Time. To access... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
33 site:2us nasdaq ghdx080720 06:57 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )